...
首页> 外文期刊>Journal of Oral and Maxillofacial Pathology >Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx
【24h】

Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx

机译:p-16,Ki-67和p-53标志物在口腔和口咽部增生和恶性病变中的表达

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Understanding the markers for predicting degree of dysplasia and progression to malignancy can help early identification and prompt treatment of patients with oral cancers. In this study, we aim to identify and characterize different tumor suppressor genes such as p-53 and p-16 and proliferation marker Ki-67 in defining stages of dysplasia of oral mucosa and grading of tumor. Settings and Design: Oral biopsy tissues (for neoplastic lesions) received for histopathological evaluation were included in the study. The sections were processed for H&E staining, and 112 cases were chosen for immunohistochemical study. The data were analyzed by Chi-square and z-tests using software SPSS. Results: We found significant correlation between degree of dysplasia and p-16 immunoexpression with 16.7% of cases showing positivity in oral intraepithelial neoplasia (OIN) I cases as compared to 25% in OIN II and 77.8% in OIN III. Ki-67 immunoexpression correlated significantly with both histological type and grade of tumor with increased expression and intensity seen in malignant cases (66.3%) as compared to benign (10%) and premalignant cases (37%) and higher Ki-67 immunoexpression in poorly differentiated tumors (75%) than well-differentiated tumors (12.2%). Regarding p-53 immunoexpression, positive staining was seen in only malignant cases and premalignant cases. Conclusions: Ki-67 and p-16 can be useful as a marker of degree of dysplasia and transformation to malignancy. Ki-67 can also serve as a marker of degree of differentiation of tumors. Hence, they can serve as important ancillary markers to analyze the transition to carcinoma, dysplasia and progression of tumor.
机译:背景:了解预测发育不良和恶性进展程度的标志物可以帮助早期识别并迅速治疗口腔癌患者。在这项研究中,我们旨在鉴定和表征不同的抑癌基因,例如p-53和p-16以及增殖标记Ki-67,以定义口腔粘膜发育不良的阶段和肿瘤的分级。设置与设计:研究中接受了用于组织病理学评估的口腔活检组织(用于肿瘤性病变)。对切​​片进行H&E染色处理,并选择112例进行免疫组织化学研究。使用软件SPSS通过卡方检验和z检验分析数据。结果:我们发现发育异常的程度与p-16免疫表达之间存在显着相关性,口腔上皮内瘤变(OIN)I病例阳性率为16.7%,OIN II为25%,OIN III为77.8%。 Ki-67免疫表达与肿瘤的组织学类型和等级显着相关,在恶性病例(66.3%)中,与良性(10%)和恶变前病例(37%)相比,其表达和强度增加,而在较差的情况中,Ki-67免疫表达较高分化的肿瘤(75%)比高分化的肿瘤(12.2%)好。关于p-53免疫表达,仅在恶性病例和恶性前病例中可见阳性染色。结论:Ki-67和p-16可作为不典型增生和向恶性转化的标志。 Ki-67也可以用作肿瘤分化程度的标志。因此,它们可以作为重要的辅助标志物,以分析其向癌的转变,不典型增生和肿瘤的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号